Conference
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC) Metastatic Non-Small Cell Lung Cancer
Authors
Antonia SJ; Gettinger S; Goldman J; Chow LQ; Juergens R; Borghaei H; Brahmer JR; Shen Y; Harbison C; Chen AC
Volume
90
Pagination
pp. s32-s33
Publisher
Elsevier
Publication Date
11 2014
DOI
10.1016/j.ijrobp.2014.08.207
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
5
ISSN
0360-3016